Year |
Citation |
Score |
2023 |
Pongor LS, Schultz CW, Rinaldi L, Wangsa D, Redon CE, Takahashi N, Fialkoff G, Desai P, Zhang Y, Burkett S, Hermoni N, Vilk N, Gutin J, Rona G, Zhao Y, ... ... Rajapakse VN, et al. Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and is Associated with Worse Outcomes. Cancer Discovery. PMID 36715552 DOI: 10.1158/2159-8290.CD-22-0796 |
0.304 |
|
2020 |
Luna A, Elloumi F, Varma S, Wang Y, Rajapakse VN, Aladjem MI, Robert J, Sander C, Pommier Y, Reinhold WC. CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics. Nucleic Acids Research. PMID 33196823 DOI: 10.1093/nar/gkaa968 |
0.318 |
|
2020 |
Tlemsani C, Pongor L, Elloumi F, Girard L, Huffman KE, Roper N, Varma S, Luna A, Rajapakse VN, Sebastian R, Kohn KW, Krushkal J, Aladjem MI, Teicher BA, Meltzer PS, et al. SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures. Cell Reports. 33: 108296. PMID 33086069 DOI: 10.1016/j.celrep.2020.108296 |
0.355 |
|
2020 |
Takashima T, Sakamoto N, Murai J, Taniyama D, Honma R, Ukai S, Maruyama R, Kuraoka K, Rajapakse VN, Pommier Y, Yasui W. Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq. Virchows Archiv : An International Journal of Pathology. PMID 32474729 DOI: 10.1007/S00428-020-02840-6 |
0.421 |
|
2019 |
Guo T, Luna A, Rajapakse VN, Koh CC, Wu Z, Liu W, Sun Y, Gao H, Menden MP, Xu C, Calzone L, Martignetti L, Auwerx C, Buljan M, Banaei-Esfahani A, et al. Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines. Iscience. 21: 664-680. PMID 31733513 DOI: 10.1016/J.Isci.2019.10.059 |
0.374 |
|
2019 |
Kaur S, Schwartz AL, Jordan DG, Soto-Pantoja DR, Kuo B, Elkahloun AG, Mathews Griner L, Thomas CJ, Ferrer M, Thomas A, Tang SW, Rajapakse VN, Pommier Y, Roberts DD. Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors. Frontiers in Oncology. 9: 994. PMID 31632920 DOI: 10.3389/Fonc.2019.00994 |
0.32 |
|
2019 |
Rajapakse VN, Takahashi N, Pongor L, Kim S, Thomas A. Abstract A048: Whole exome sequencing of circulating free DNA reveals concordance with matched metastatic tumors and predicts survival in small cell lung cancer patients Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-A048 |
0.312 |
|
2018 |
Rajapakse VN, Luna A, Yamade M, Loman L, Varma S, Sunshine M, Iorio F, Sousa FG, Elloumi F, Aladjem MI, Thomas A, Sander C, Kohn KW, Benes CH, Garnett M, et al. CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines. Iscience. PMID 30553813 DOI: 10.1016/J.Isci.2018.11.029 |
0.45 |
|
2018 |
Greer YE, Porat-Shliom N, Nagashima K, Stuelten C, Crooks D, Koparde VN, Gilbert SF, Islam C, Ubaldini A, Ji Y, Gattinoni L, Soheilian F, Wang X, Hafner M, Shetty J, ... ... Rajapakse V, et al. ONC201 kills breast cancer cells by targeting mitochondria. Oncotarget. 9: 18454-18479. PMID 29719618 DOI: 10.18632/Oncotarget.24862 |
0.373 |
|
2018 |
Tang SW, Thomas A, Murai J, Trepel J, Bates SE, Rajapakse VN, Pommier Y. Overcoming resistance to DNA targeted agents by epigenetic activation of Schlafen 11 (SLFN11) expression with class I histone deacetylase inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29391350 DOI: 10.1158/1078-0432.Ccr-17-0443 |
0.36 |
|
2018 |
Ghafoor A, Tang S, Thomas A, Murai J, Trepel JB, Bates SE, Rajapakse VN, Pommier Y. Abstract LB-244: Overcoming resistance to DNA targeted agents by epigenetic activation of Schlafen 11 (SLFN11) expression with class I histone deacetylase inhibitors Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-244 |
0.415 |
|
2018 |
Greer YE, Gilbert S, Islam C, Ubaldini A, Stuelten C, Porat-Shliom N, Weigert R, Ji Y, Gattinoni L, Soheilian F, Nagashima K, Wang X, Hafner M, Shetty J, Tran B, ... ... Rajapakse V, et al. Abstract B023: ONC201 kills breast cancer cells by targeting mitochondria Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-B023 |
0.354 |
|
2017 |
Takiuchi Y, Kobayashi M, Tada K, Iwai F, Sakurada M, Hirabayashi S, Nagata K, Shirakawa K, Shindo K, Yasunaga JI, Murakawa Y, Rajapakse V, Pommier Y, Matsuoka M, Takaori-Kondo A. HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia. Scientific Reports. 7: 12849. PMID 28993637 DOI: 10.1038/S41598-017-12924-0 |
0.386 |
|
2017 |
Al Abo M, Sasanuma H, Liu X, Rajapakse VN, Huang SN, Kiselev E, Takeda S, Plunkett W, Pommier Y. TDP1 is critical for the repair of DNA breaks induced by sapacitabine, a nucleoside also targeting ATM- and BRCA-deficient tumors. Molecular Cancer Therapeutics. PMID 28802254 DOI: 10.1158/1535-7163.Mct-17-0110 |
0.437 |
|
2017 |
Thomas A, Tanaka M, Trepel J, Reinhold WC, Rajapakse VN, Pommier Y. Temozolomide in the Era of Precision Medicine. Cancer Research. PMID 28159862 DOI: 10.1158/0008-5472.Can-16-2983 |
0.421 |
|
2017 |
Rajapakse VN, Luna A, Sander C, Reinhold WC, Pommier Y. Abstract 2586: CellMinerCDB: Enabling cross-database exploration of molecular pharmacology data and response determinant discovery in cancer cell lines Cancer Research. 77: 2586-2586. DOI: 10.1158/1538-7445.Am2017-2586 |
0.376 |
|
2016 |
Reinhold WC, Varma S, Sunshine M, Rajapakse V, Luna A, Kohn KW, Stevenson H, Wang Y, Heyn H, Nogales V, Moran S, Goldstein DJ, Doroshow JH, Meltzer PS, Esteller M, et al. The NCI-60 Methylome and its Integration into CellMiner. Cancer Research. PMID 27923837 DOI: 10.1158/0008-5472.Can-16-0655 |
0.452 |
|
2016 |
Mameri H, Bieche I, Meseure D, Marangoni E, Buhagiar-Labarchède G, Nicolas A, Vacher S, Onclercq-Delic R, Rajapakse V, Varma S, Reinhold WC, Pommier Y, Amor-Guéret M. Cytidine deaminase deficiency reveals new therapeutic opportunities against cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27601591 DOI: 10.1158/1078-0432.Ccr-16-0626 |
0.358 |
|
2015 |
Luna A, Rajapakse VN, Sousa FG, Gao J, Schultz N, Varma S, Reinhold W, Sander C, Pommier Y. rcellminer: Exploring Molecular Profiles and Drug Response of the NCI-60 Cell Lines in R. Bioinformatics (Oxford, England). PMID 26635141 DOI: 10.1093/Bioinformatics/Btv701 |
0.331 |
|
2015 |
Tang SW, Bilke S, Cao L, Murai J, Sousa FG, Yamade M, Rajapakse V, Varma S, Helman LJ, Khan J, Meltzer PS, Pommier Y. SLFN11 is a transcriptional target of EWS-FLI1 and a determinant of drug response in Ewing's sarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 25779942 DOI: 10.1158/1078-0432.Ccr-14-2112 |
0.413 |
|
2015 |
Sousa FG, Matuo R, Tang SW, Rajapakse VN, Luna A, Sander C, Varma S, Simon PH, Doroshow JH, Reinhold WC, Pommier Y. Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity. Dna Repair. 28: 107-15. PMID 25758781 DOI: 10.1016/J.Dnarep.2015.01.011 |
0.469 |
|
2015 |
Reinhold WC, Varma S, Rajapakse VN, Luna A, Sousa FG, Kohn KW, Pommier YG. Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancer. Human Genetics. 134: 3-11. PMID 25213708 DOI: 10.1007/S00439-014-1482-9 |
0.454 |
|
2014 |
Pommier Y, Bilke SW, Sousa F, Yamade M, Murai J, Rajapakse V, Helman L, Meltzer P. 252 The DNA damage response gene Schlafen 11 (SLFN11) is a transcriptional target of ETS transcription factors in Ewing's sarcoma and other cancers European Journal of Cancer. 50: 84. DOI: 10.1016/S0959-8049(14)70378-8 |
0.375 |
|
2012 |
Rajapakse VN, Czaja W, Pommier YG, Reinhold WC, Varma S. Predicting expression-related features of chromosomal domain organization with network-structured analysis of gene expression and chromosomal location 2012 Acm Conference On Bioinformatics, Computational Biology and Biomedicine, Bcb 2012. 226-233. DOI: 10.1145/2382936.2382965 |
0.541 |
|
2011 |
Ehler M, Rajapakse VN, Zeeberg BR, Brooks BP, Brown J, Czaja W, Bonner RF. Nonlinear gene cluster analysis with labeling for microarray gene expression data in organ development. Bmc Proceedings. 5: S3. PMID 21554761 DOI: 10.1186/1753-6561-5-S2-S3 |
0.572 |
|
2011 |
Zeeberg BR, Liu H, Kahn AB, Ehler M, Rajapakse VN, Bonner RF, Brown JD, Brooks BP, Larionov VL, Reinhold W, Weinstein JN, Pommier YG. RedundancyMiner: De-replication of redundant GO categories in microarray and proteomics analysis. Bmc Bioinformatics. 12: 52. PMID 21310028 DOI: 10.1186/1471-2105-12-52 |
0.415 |
|
2010 |
Ehler M, Rajapakse V, Zeeberg B, Brooks B, Brown J, Czaja W, Bonner RF. Analysis of temporal-spatial co-variation within gene expression microarray data in an organogenesis model Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 6053: 38-49. DOI: 10.1007/978-3-642-13078-6_6 |
0.558 |
|
2004 |
Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, Kawaguchi Y, Johann D, Liotta LA, Crawford HC, Putt ME, et al. Erratum: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse (Cancer Cell (4) (437-450)) Cancer Cell. 5. DOI: 10.1016/S1535-6108(03)00335-0 |
0.33 |
|
2003 |
Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, Kawaguchi Y, Johann D, Liotta LA, Crawford HC, Putt ME, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 4: 437-50. PMID 14706336 DOI: 10.1016/S1535-6108(03)00309-X |
0.311 |
|
Show low-probability matches. |